Patent Assignment
Reel/Frame 025710/0949
Assignment of Assignor's Interest
Recorded: 2011-01-28
Pages: 7
Assignor
ALKERMES, INC.
Executed: 2011-01-26
Assignee
CORREGIDOR THERAPEUTICS, INC.
384 POWDER MILL ROAD, CONCORD, MASSACHUSETTS, 01742
Covered Properties
(61)
Aggregated Porous Particles Emitted from an Inhaler
Application:
09/337,245 →
Use of Simple Amino Acids to Form Porous Particles During Spray Drying
Patent:
6,586,008 →
Application:
09/382,959 →
Stable Spray- Dried Protein Formulations
Patent:
6,956,021 →
Application:
09/383,054 →
High Efficient Delivery of a Large Therapeutic Mass Aerosol
Patent:
6,858,199 →
Application:
09/591,307 →
Formulation for Spray-Drying Large Porous Particles
Patent:
6,749,835 →
Application:
09/644,105 →
Use of Simple Amino Acids to Form Porous Particles
Patent:
7,252,840 →
Application:
09/644,320 →
Modulation of release from dry powder formulations
Application:
09/644,736 →
Pulmonary Delivery in Treating Disorders of the Central Nervous System
Patent:
6,514,482 →
Application:
09/665,252 →
Particles for inhalation having sustained release properties
Application:
09/752,109 →
Modulation of release from dry powder formulations
Application:
09/792,869 →
Publication:
US 2001/0036481
Particles for Inhalation Having Sustained Release Properties
Control of Process Humidity to Produce Large, Porous Particles
Pulmonary Delivery in Treating Disorders of the Central Nervous System
Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
Particles for inhalation having rapid release properties
Application:
09/888,126 →
Publication:
US 2002/0141946
Particles for inhalation having rapid release properties
Application:
10/179,463 →
Publication:
US 2003/0125236
Particles for Inhalation Having Sustained Release Properties
Compositions for sustained action product delivery and methods of use thereof
Application:
10/300,070 →
Publication:
US 2003/0166509
Particulate Compositions for Pulmonary Delivery
Inhalable Sustained Therapeutic Formulations
Pulmonary Delivery for Levodopa
Modulation of release from dry powder formulations
Application:
10/425,193 →
Publication:
US 2004/0018243
Modulation of release from dry powder formulations
Application:
10/425,194 →
Publication:
US 2005/0003003
Pulmonary Delivery in Treating Disorders of the Central Nervous System
Inhalable Epinephrine
Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
Pulmonary delivery in treating disorders of the central nervous system
Application:
10/762,200 →
Publication:
US 2004/0228923
Formulation for Spray-Drying Large Porous Particles
Low Dose Pharmaceutical Powders for Inhalation
Pulmonary delivery in treating disorders of the central nervous system
Application:
10/895,577 →
Publication:
US 2004/0265242
Control of Process Humidity to Produce Large, Porous Particles
Stable spray-dried protein formulations
Application:
11/176,841 →
Publication:
US 2006/0002996
Particles for inhalation having sustained release properties
Application:
11/436,404 →
Publication:
US 2008/0039366
Particulate Compositions for Pulmonary Delivery
Use of simple amino acids to form porous particles
Application:
11/637,353 →
Publication:
US 2007/0104658
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
Application:
11/838,468 →
Publication:
US 2008/0063722
Particles for Inhalation Having Rapid Release Properties
Application:
11/860,302 →
Publication:
US 2008/0226730
Particles for Inhalation Having Rapid Release Properties
Application:
11/860,357 →
Publication:
US 2008/0227690
Formulations for Spray-Drying Large Porous Particles
Use of Simple Amino Acids to Form Porous Particles
Application:
11/873,467 →
Publication:
US 2008/0160092
Use of Simple Amino Acids to Form Porous Particles
Application:
11/873,472 →
Publication:
US 2008/0160098
Pulmonary Delivery in Treating Disorders of the Central Nervous System
Application:
12/166,704 →
Publication:
US 2009/0162441
Pulmonary Pharmaceutical Formulations
Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
Application:
12/253,449 →
Publication:
US 2009/0068274
Inhalable Sustained Therapeutic Formulations
Application:
12/721,640 →
Inhalable Sustained Therapeutic Formulations
Application:
12/907,584 →
Publication:
US 2011/0123574
Large Porous Particles Emitted from an Inhaler
Application:
60/090,454 →
Stable Spray-Dried Protein Formulations
Application:
60/097,796 →
Formulation for Spray-Drying Large Porous Particles
Application:
60/150,662 →
Modulation of Release from Dry Powder Formulations by Controlling Matrix Transition
Application:
60/150,742 →
Compositions for sustained action drug delivery and methods of use thereof
Application:
60/331,707 →
High surface area particles for inhalation
Application:
60/331,708 →
Compositions for sustained action product delivery and methods of use thereof
Application:
60/365,660 →
Pulmonary delivery for levodopa
Application:
60/366,471 →
Inhalable sustained therapeutic formulations
Application:
60/366,479 →
Inhalable epinephrine
Application:
60/393,007 →
Inhalable epinephrine
Application:
60/393,716 →
Inhalable epinephrine
Application:
60/425,349 →
Low dose pharmaceutical powders for inhalation
Application:
60/478,315 →
Composition of a spray-dried powder for pulmonary delivery of a Long-Acting Neuraminidase Inhibitor (LANI)
Application:
60/843,320 →
Pulmonary Pharmaceutical Formulations
Application:
60/957,108 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Jun 2, 2009
From: ADVANCED INHALATION RESEARCH, INC.
To: ALKERMES, INC.
Reel/Frame 022764/0088 →
Assignment of Assignor's Interest
Jan 28, 2011
From: ALKERMES, INC.
To: CORREGIDOR THERAPEUTICS, INC.
Reel/Frame 025711/0278 →
Change of Name
Feb 3, 2011
From: CORREGIDOR THERAPEUTICS, INC.
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 025741/0450 →
Nunc Pro Tunc Assignment
Jan 6, 2025
From: CIVITAS THERAPEUTICS, INC.
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 069752/0843 →